The Top Line cover image

Misconduct and the future of neurodegenerative disease research

The Top Line

CHAPTER

Investigating Misconduct in Alzheimer's Research

This chapter explores the investigative efforts regarding alleged misconduct linked to Cassava Sciences and its Alzheimer's drug, Simufalam. It highlights the integrity concerns that arose from the data and the broader implications for patients in clinical trials, pointing to a significant crisis in neurodegenerative disease research.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner